Navigation Links
Warfarin Safer Than Heparin for Some Strokes
Date:7/14/2008

When clot forms in heart and travels to the brain, heparin more risky, study finds

MONDAY, July 14 (HealthDay News) -- The widely prescribed blood-thinning drug heparin is associated with an increased risk of serious bleeding in patients who have suffered a cardioembolic stroke, new research shows.

But another thinning agent, warfarin, did not seem to have any harmful effects in the same group of patients.

This finding led the authors of a study published online Monday and in the September print issue of the Archives of Neurology to suggest that warfarin appears to be safe and could be started at any time while a patient is hospitalized.

According to the American Heart Association, a cardioembolic stroke occurs when a clot or other particle originally forms in the heart then travels to a narrowed artery in the brain.

This type of stroke represents about one-fifth of ischemic strokes, those which involve reduced blood flow to the brain, the researchers said.

Although current guidelines don't recommend giving anti-clotting therapy right after a cardioembolic stroke, most patients with this condition will end up needing such therapy. The question is when, and with what drug.

Warfarin can do the trick but often takes days to reach effective levels so, in the interim, is combined with other therapies.

For this study, researchers at the University of Texas Health Science Center at Houston reviewed the records of 204 patients who had had a cardioembolic stroke and were admitted to the hospital between 2004 and 2006.

Eight patients received no anti-clotting therapy at all; 88 received aspirin (a blood thinner) alone; 35 received aspirin and warfarin; 44 received heparin intravenously with warfarin; and 29 received a full dose of enoxaparin, a low-molecular-weight heparin then warfarin.

Participants who did not get full doses of heparin or enoxaparin instead received low-dose enoxaparin to prevent blood clots in the legs.

Five percent of patients had a progressive stroke (their conditions continued to decline even after the acute phase of the stroke was over); all but one of these cases occurred in the aspirin-only group.

In addition, patients receiving aspirin alone were more than 12 times as likely to have stroke progression compared with patients taking other types of therapies.

Eleven percent of patients experiencing bleeding into the brain tissue. Only three, however, were symptomatic, and all of these had been taking full-dose enoxaparin. Two patients taking heparin had systemic bleeding.

Adding enoxaparin or heparin to warfarin increased the risks of bleeding but could be considered in certain circumstances, the authors stated.

More information

Visit the American Heart Association for more on different kinds of stroke.



--HealthDay staff



SOURCE: Archives of Neurology, press release, July 14, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. DNA Direct and Iverson Genetics Announce Partnership to Provide Personalized Patient Reports for Warfarin Dosing Test Results
2. AHRQ Announces Guide to Help Patients on Coumadin(R)/Warfarin Therapy
3. Genetic Test Predicts Response to Warfarin
4. AutoGenomics Receives FDA Clearance for its INFINITI(TM) Warfarin Assay
5. Drug interactions with warfarin
6. WHO Creates New Surgical Tool to Make Operations Safer Everywhere
7. VHA Foundation Launches National CEO Patient SafetyNetwork, Starting From the Top to Make Patients Safer
8. Making the Outdoors Safer for Communities: the American Academy of Dermatology Announces 2008 AAD Shade Structure Program Grant Recipients
9. New Technology Promises Safer Organ Transplants and Soft Tissue Surgeries
10. Penn research offers road map to safer pain control, cost savings during colonoscopies
11. Social Networking Sites Safer Than IM or Chat Rooms
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Warfarin Safer Than Heparin for Some Strokes
(Date:5/6/2016)... ... May 06, 2016 , ... DrugDev President and CEO ... the pharmaceutical industry conducts clinical trials. This month Ibs was named No. 20 on ... and he was honored as a Tech Disruptor by the Philadelphia Business Journal. , ...
(Date:5/6/2016)... ... 06, 2016 , ... Featured cast and producers of the ... at the 2016 Learning Summit , June 12-15, in Paradise Valley, Arizona. ... stories—of complicated family issues, financial difficulties, and other personal obstacles—are the stories of ...
(Date:5/6/2016)... ... May 06, 2016 , ... A wide variety of national pet product manufacturers, companies and ... Safety Media Showcase Wednesday, May 18 from noon to 8 p.m. at New York City’s ... at new and established home, garden, outdoor and safety pet products in today’s marketplace. ...
(Date:5/6/2016)... ... May 06, 2016 , ... ... an upcoming episode, airing third quarter 2016, via Discovery Channel. Dates and show ... a leader in optimized drug discovery through innovative cellular analysis. In this segment, ...
(Date:5/6/2016)... ... May 06, 2016 , ... Logically, spring weather, with its moderate ... weather is too cold, dry or hot, water on the eye surface can evaporate, ... from the surrounding air. There’s only one problem, according to radio show and water ...
Breaking Medicine News(10 mins):
(Date:5/5/2016)... -- Endo International plc (NASDAQ: ENDP ) ... , President, U.S. Branded Pharmaceuticals, has decided to ... of a successor. Mr. Lortie joined Endo in ... responsibility for all strategic, commercial and operational functions, ... commercial operations, managed markets, manufacturing, supply chain and ...
(Date:5/5/2016)... ORANGE COUNTY, Calif. , May 5, 2016 ... for nearly a decade due to concerns that ... advances in the approach to imaging, as well ... in a new era of medical peripherals that ... better care.   Ampronix  advanced medical imaging is a ...
(Date:5/5/2016)... , May 5, 2016 /PRNewswire/ ... announced the addition of the  "Europe ... - 2016"  report to their offering.  ... ) , ,The latest research ... Highlights - 2016, provides comprehensive insights ...
Breaking Medicine Technology: